<?xml version="1.0" encoding="UTF-8"?>
<p>To our knowledge, this is the first human trial that has investigated the outcome of hUCB‐MSC infusions in patients with RA. A recent study used human umbilical cord (hUC)‐derived MSCs to RA patients, which differ from hUCB‐MSC in terms of source and preparation of the investigational product 
 <xref rid="sct312331-bib-0019" ref-type="ref">19</xref>. Our group has previously investigated the detailed mechanism by which hUCB‐MSC infusions can ameliorate inflammatory arthritis 
 <xref rid="sct312331-bib-0012" ref-type="ref">12</xref>. This phase Ia study extends our preclinical research, investigating the safety and tolerability of a single intravenous infusion of hUCB‐MSCs in Korean patients with RA.
</p>
